Company Filing History:
Years Active: 2024
Title: Thomas Engber: Innovator in Neurodegenerative Disease Treatment
Introduction
Thomas Engber is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of neurodegeneration through his innovative research and development of therapeutic methods.
Latest Patents
Engber holds a patent for "Inhibitors of SARM1 in combination with neuro-protective agents." This patent focuses on methods for treating neurodegeneration and neurodegenerative diseases. The present disclosure relates to administering a combination of a SARM1 inhibitor and a neuroprotective agent to a subject in need.
Career Highlights
Engber is currently associated with Disarm Therapeutics, Inc., where he continues to advance his research in neuroprotective therapies. His work is pivotal in developing new treatment options for patients suffering from neurodegenerative conditions.
Collaborations
Engber collaborates with talented professionals in his field, including Todd Bosanac and Rajesh Devraj. Their combined expertise enhances the innovative efforts at Disarm Therapeutics, Inc.
Conclusion
Thomas Engber's contributions to neurodegenerative disease treatment through his patent and work at Disarm Therapeutics, Inc. highlight his commitment to advancing medical science. His innovative approaches are paving the way for new therapeutic options in this critical area of healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.